Filing Details
- Accession Number:
- 0001213900-23-067446
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-08-15 08:00:17
- Reporting Period:
- 2023-08-15
- Accepted Time:
- 2023-08-15 08:00:17
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1733413 | Tff Pharmaceuticals Inc. | TFFP | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1555563 | F Harlan Weisman | 1751 River Run, Suite 400 Fort Worth TX 76107 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-08-15 | 600,000 | $0.25 | 814,615 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Acquired from the Issuer pursuant to the public offering described in the Issuer's Prospectus filed with the U.S. Securities and Exchange Commission on August 14, 2023.
Billionaire Hedge Funds
